Shyama Computronics and Services logo

Shyama Computronics and Services PE ratio history and valuation

BSE: 531219Pharmaceuticals & BiotechnologySmall Cap

Shyama Computronics and Services Limited · Face value ₹10 · Listed Nov 1995
Last close ₹3.70₹0.00 (0.00%)

Share price at the BSE close on 28 Oct 2026. Previous close ₹3.70.

28 Oct: open ₹3.88, high ₹3.88, low ₹3.70

52-week range of traded prices to 28 Oct 2026
₹2.38Low, 23 Jul 2026₹5.55High, 18 Jun 2026
Market cap
₹3.72 Cr5,121st largest listed
P/E
Earlier quarters restated in the year
P/B
0.36
Dividend yield
Nonein the last 12 months
ROCE
0.6%
Debt to equity
0.00
Volume, BSE
700

Shyama Computronics and Services' price to book, price to sales, EV to EBITDA and dividend yield on 28 Oct 2026. Each gets a history once a year of trading is on record. Its P/E is not shown: the figures it needs for the twelve months to Jun 2026 are not complete or not comparable.

Shyama Computronics and Services PE ratio and valuation against its own history

  • Price to earningsA results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement
  • Price to book0.36today
  • Price to sales13.05today
  • EV to EBITDA59.14today
  • Dividend yield0.00%today
  • Earnings yieldA results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement

Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures
  • Price to book =Market cap÷Net worth₹10 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹0.29 Cr
  • Enterprise value =Market cap+Borrowings₹0.00 Cr−Cash₹0.01 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹0.06 Cr
  • Market cap =Close×Shares in issue1,00,64,400at 30 Sep 2026

Standalone accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Shyama Computronics and Services financials ›

Shyama Computronics and Services valuation at each year end

On the last trading day of each March, the month the company's year ends.

RatioMar 2019Mar 2023Mar 2024Mar 2025Mar 2026
Market cap (₹ crore)1.243.955.413.773.02
Price to earningsProfit not stated239.148.528.8Earlier quarters restated in the year
Price to book0.10.40.50.40.3
Price to sales3.127.227.815.910.6
EV to EBITDAOperating profit not statedOperating lossOperating lossOperating loss44.1
Dividend yield0.00%0.00%0.00%0.00%0.00%
Earnings yieldProfit not stated0.4%2.1%3.5%Earlier quarters restated in the year
A ratio that does not exist on the day says why in its cell.

Shyama Computronics and Services market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap
₹7.51 Cr₹0.92 Cr₹3.72 CrNov 16Jul 18Jan 20Jul 23Apr 24Jan 25Oct 25Oct 26

Book value and enterprise value

From the close on 28 Oct 2026.

Enterprise value
₹3.71 Cr
Book value per share
₹10.18
Dividends, last 12 months
None
Public's market cap
₹3.72 Cr

Against Pharmaceuticals

215 listed companies in Pharmaceuticals, each priced on its last trading day; Shyama Computronics and Services is 215th among them by market cap. Each median leaves out Shyama Computronics and Services itself and takes the other companies that have the figure.

Industry median P/E
28.1Across 157 other companies
Industry median P/B
3.0Across 190 other companies
Industry median EV/EBITDA
18.9Across 143 other companies
Industry median dividend yield
0.49%Across 89 other companies
Company
Beryl Drugs logoBeryl DrugsBERLDRG1320.991.338.40.00%
Unjha Formulations logoUnjha FormulationsUNJHAFOR1225.643.1514.20.00%
Ortin Global logoOrtin GlobalORTINGLOBE10–8.16–0.00%
Dipna Pharmachem logoDipna PharmachemDPL10–––0.00%
Brawn Biotech logoBrawn BiotechBRAWN89.041.79–0.00%
Vivanza Biosciences logoVivanza BiosciencesVIVANZA613.211.3832.00.00%
Decipher Labs logoDecipher LabsDECIPHER6–0.67–0.00%
Advik Laboratories logoAdvik LaboratoriesADVIKLA4–58.03–0.00%
Shyama Computronics and Services logoShyama Computronics and ServicesSHYAMACOMP4–0.3659.10.00%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.